Aurobindo Metformin 1000mg Recall: Foreign Tablet Hazard
Aurobindo Pharma recalls 7,476 bottles of Metformin HCl 1000mg tablets due to the presence of a foreign tablet (Metformin BP). Check your lot number.
Use caution until it’s fixed
Presence of Foreign Tablet: Metformin BP 1000mg was found in bottle of Metformin HCl 1000mg
Contact the company
What happened, in plain English
Aurobindo Pharma Ltd. is recalling 7,476 bottles of Metformin Hydrochloride Tablets, USP 1000 mg because a bottle was found to contain a foreign tablet. Specifically, Metformin BP 1000mg was discovered in the bottle intended for Metformin HCl 1000mg. The recall affects bottles distributed nationwide within the US. Read more at govinfonow.com/recall/40893-aurobindo-metformin-1000mg-recall-foreign-tablet-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/40893-aurobindo-metformin-1000mg-recall-foreign-tablet-hazard · Updated October 11, 2026 · FDA enforcement record: FDA #D-0427-2018
Cite this page
“Aurobindo Metformin 1000mg Recall: Foreign Tablet Hazard.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/40893-aurobindo-metformin-1000mg-recall-foreign-tablet-hazard. Based on FDA recall #D-0427-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0427-2018%22&limit=1).
Why it’s dangerous
The hazard is the presence of a foreign tablet (Metformin BP) within a bottle labeled as Metformin HCl. While both are forms of metformin, the presence of an unlisted or different formulation in a prescription bottle creates a risk of medication error or unexpected physiological response.
Who’s affected
Patients who have been prescribed Metformin Hydrochloride Tablets, USP 1000 mg from Aurobindo Pharma and possess a bottle with lot number MTSC17145-A. These individuals are at risk of ingesting the wrong medication variant.
How to tell if you have this one
Check your bottle for the following details: Product is Metformin Hydrochloride Tablets, USP 1000 mg; NDC is 65862-010-05; Lot number is MTSC17145-A; Expiration date is July 2021. The bottles contain 500 tablets and are Rx Only.
- Brand
Aurobindo Pharma- Category
Drug
What to do — step by step
Check your bottle details
Verify if your bottle matches the recalled lot number MTSC17145-A, NDC 65862-010-05, and expiration date July 2021.
Contact your pharmacist
If you have the recalled bottle, contact your pharmacy or healthcare provider immediately for guidance on replacement or disposal.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the US” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3 years after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0427-2018 (February 2, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0427-2018 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.